1 / 8

Malaysia IVIG Market worth $18,649 Thousand by 2022

The Malaysia IVIG market accounted for $12,277 thousand in 2015, and is estimated to reach at $18,649 thousand by 2022, registering a CAGR of 6.1% from 2016 to 2022.

sanketsolanki
Download Presentation

Malaysia IVIG Market worth $18,649 Thousand by 2022

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Malaysia IVIG Marketto Reach $18,649 Thousand by 2022

  2. The Malaysia IVIG market accounted for $12,277 thousand in 2015, and is estimated to reach at $18,649 thousand by 2022, registering a CAGR of 6.1% from 2016 to 2022. Introduction • The scope of applications of IVIG has widened, as it is used to treat various neurological, hematological, dermatological, and immune deficiency disorders, with the help of improved clinical practices and advanced technologies. • Rise in immunodeficiency diseases among populace, increase in adoption of IVIG, and rise in ageing population in Malaysia are the major factors that augment market growth. • The  Malaysia IVIG market is segmented based on product type, application, mode of delivery, and concentration.

  3. Hypogammaglobulinemia accounted for the largest revenue in 2015 owing to the lack of effective substitute treatment, and early adoption of IVIG • Myasthenia gravis is anticipated grow at the fastest CARG of 9.1% in the forecast period. • The intravenous mode of delivery was the highest revenue generating segment in 2015 and is anticipated to continue this trend during the forecast period. • 10% concentration held the highest market share in 2015. This trend is likely to continue throughout the forecast period. Key Findings of theMarket

  4. This report entails a detailed quantitative analysis of the current market trends to identify the prevailing opportunities, during the period, 2014‐2022 • It presents market estimations  based on comprehensive analysis of the key developments in the industry • In-depth product analysis to understand the regional market and the strategic business planning. • The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market. Key Benefits Get Access to TOC / Sample Report @ https://www.alliedmarketresearch.com/request-sample/2281

  5. By Application • Hypogammaglobulinemia • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) • Immunodeficiency Diseases • Myasthenia Gravis • Multifocal Motor Neuropathy • Idiopathic Thrombocytopenic Purpura (ITP) • Inflammatory Myopathies • Specific Antibody Deficiency • Guillain-Barr Syndrome • Kawasaki Disease • Secondary Immune Deficiency • Others MarketSegmentation • By Product • IgG • IgA • IgM • IgE • IgD • By Mode of Delivery • Intravenous • Intramuscular • Subcutaneous • By Concentration • 5% Concentration • 10% Concentration • Other Concentration

  6. Key Players of theMarket • BDI Pharma, Inc., • China Biologics Products, Inc., • LFB Biotechnologies, • HualanBiological Engineering Inc, • GuizhouTaibang Biological Products Co., Ltd.,  • Others For purchase enquiry, visit @https://www.alliedmarketresearch.com/purchase-enquiry/2281

  7. About Allied MarketResearch: Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective marketdomain. ContactUs: 5933 NE Win Sivers Drive, #205, Portland, OR 97220, UnitedStates. Int'l: +1-503-894-6022 TollFree: +1-800-792-5285 Fax: +1-800-792-5285 Contact Allied MarketResearch

  8. ThankYou! For MoreDetails Visit usat https://www.alliedmarketresearch.com/malaysia-intravenous-immunoglobulin-ivig-market Follow UsOn:

More Related